Vertebral osteomyelitis due to Candida parapsilosis in a child with Crohn disease while receiving anti-TNF therapy

J Pediatr Gastroenterol Nutr. 2013 Apr;56(4):e23-6. doi: 10.1097/MPG.0b013e31827ecbda.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Candida / drug effects
  • Candida / immunology
  • Candida / isolation & purification
  • Candidiasis / complications
  • Candidiasis / drug therapy
  • Candidiasis / immunology*
  • Candidiasis / microbiology
  • Child
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology
  • Crohn Disease / microbiology
  • Drug Resistance, Fungal
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Opportunistic Infections / complications
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / immunology*
  • Opportunistic Infections / microbiology
  • Osteomyelitis / complications
  • Osteomyelitis / drug therapy
  • Osteomyelitis / immunology*
  • Osteomyelitis / microbiology
  • Spondylitis / complications
  • Spondylitis / drug therapy
  • Spondylitis / immunology*
  • Spondylitis / microbiology
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antifungal Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha

Supplementary concepts

  • Pediatric Crohn's disease